Robert Willett - 18 Feb 2025 Form 4 Insider Report for COGNEX CORP (CGNX)

Role
CEO & President, Director
Signature
Robert Willett
Issuer symbol
CGNX
Transactions as of
18 Feb 2025
Transactions value $
$0
Form type
4
Filing time
20 Feb 2025, 17:10:25 UTC
Previous filing
23 May 2024
Next filing
23 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CGNX Common Stock 15.8K 18 Feb 2025 by Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGNX Non-Qualified Stock Option (right to buy) Award $0 +193K $0.00 193K 18 Feb 2025 Common Stock 193K $33.04 Direct F2
transaction CGNX Restricted Stock Unit Award $0 +70.8K $0.00 70.8K 18 Feb 2025 Common Stock 70.8K $0.00 Direct F3, F4
holding CGNX Non-Qualified Stock Option (right to buy) 180K 18 Feb 2025 Common Stock 180K $38.39 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 298K 18 Feb 2025 Common Stock 298K $39.44 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 233K 18 Feb 2025 Common Stock 233K $47.21 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 180K 18 Feb 2025 Common Stock 180K $50.94 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 180K 18 Feb 2025 Common Stock 180K $51.49 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 90K 18 Feb 2025 Common Stock 90K $56.44 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 185K 18 Feb 2025 Common Stock 185K $64.43 Direct
holding CGNX Non-Qualified Stock Option (right to buy) 124K 18 Feb 2025 Common Stock 124K $90.50 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is a trustee and beneficiary of Willett Parkhill Investment Trust dated August 2, 2010. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
F2 The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025).
F3 Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
F4 The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 18, 2025), respectively.